Yang Tian

692 citations
34 papers · 518 indexed · h-index 12
Topics
Ferroptosis and cancer prognosis (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)Cell Adhesion Molecules Research (3 papers)
Partner nations
ChinaJapan

In The Last Decade

Yang Tian

34 papers receiving 513 citations

Peers

Yang Tian
Comparison fields: 5 of 86
  • Molecular Biology 331
  • Oncology 140
  • Cancer Research 138
  • Immunology 91
  • Pulmonary and Respiratory Medicine 72
Replace Ying-Hua Jiang with:
Ying-Hua Jiang China
Yang Han China
Qiang Feng China
Alexandra Canonici Ireland
Ahmed Atef Ibrahim United States
Umarani Pugazhenthi United States
Lixia Miao China
Ji Hye Shin South Korea
Yang Tian relative to Ying-Hua Jiang China Ying-Hua Jiang's profile →
Citations per field
00.5×1.5×2.1×
Ying-Hua Jiang · 1×
Citations per year

Countries citing papers authored by Yang Tian

Since Specialization
Citations

This map shows the geographic impact of Yang Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Tian more than expected).

Fields of papers citing papers by Yang Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Tian. The network helps show where Yang Tian may publish in the future.

Co-authorship network of co-authors of Yang Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Tian. A scholar is included among the top collaborators of Yang Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Tian. Yang Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 1
4 2
5 8
6 8
7 2
8 5
9 9
10 50
11 71
12 16
13 43
14 1
15 21
16 2
17 23
18 5
19 7
20
[Total syndactylism with mesomelic shortening of the arm, radioulnar and metacarpal synostoses and disorganization of the phalanges ("cenani syndactylism") (author's transl)].
8

About Yang Tian

Yang Tian is a scholar working on Developmental Biology, Immunology and Allergy and Oncology, having authored 34 papers that have together received 518 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Cancer Research (138 citations), Oncology (140 citations) and Molecular Biology (331 citations). Yang Tian has collaborated with scholars based in China and Japan. Frequent co-authors include Yan Fu, Jie Liu, Yongzhang Luo, Chunying Wang, Shaosen Zhang, Wei Song, Yan Li, Ming Li, Rui Jiang and Yongzhang Luo. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026